abstract |
The present invention relates to the ranking/selection of tumor-specific neoantigens of a subject having cancer. The present invention also provides methods using the ranked/selected tumor-specific neoantigens in, for example, the treatment or prevention of cancer. Ranked and selected neoantigens may be used as biomarkers in the diagnosis, monitoring and/or prognosis of tumor diseases. |